Yusuke Nagata

High blood levels of soluble OX40 (CD134), an immune costimulatory molecule, indicate reduced survival in patients with advanced colorectal cancer

Ryoichi Sawada, Yoshinori Arai, Yukiko Sagawa et al. · Oncology Reports · 2019 · 23 citations · Full text

Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in gastrointestinal cancer patients with massive ascites treated with systemic chemotherapy

Yusuke Nagata, Ken Kato, Takahiro Miyamoto et al. · Supportive Care in Cancer · 2020 · 19 citations

Systemic Chemotherapy, Surgical Oncology, Gastrointestinal Oncology +9

Endotoxin-induced liver injury after extended hepatectomy and the role of kupffer cells in the rat

Yusuke Nagata, Noriam Tanaka, Kunzo Orita · Surgery Today · 1994 · 18 citations

Immunology, Pathology, Endotoxin-induced Liver Injury +16

Efficacy and safety of pemetrexed plus cisplatin as first-line chemotherapy in advanced malignant peritoneal mesothelioma

Yusuke Nagata, Ryoichi Sawada, Atsuo Takashima et al. · Japanese Journal of Clinical Oncology · 2019 · 16 citations

The SHAP–hyaluronan complex in serum from patients with chronic liver diseases caused by hepatitis virus infection

Luhui Shen, A. Okumura, Tetsuya Ishikawa et al. · Hepatology Research · 2006 · 14 citations